InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
Frequently asked questions
What sector does InnoCan Pharma Corporation (INNPF) operate in?
InnoCan Pharma Corporation belongs to the Healthcare sector and operates in the Household & Personal Products industry.
What is InnoCan Pharma Corporation (INNPF) current stock price?
As of the latest data, InnoCan Pharma Corporation stock price is $1.29, with a previous close of $1.30. InnoCan Pharma Corporation lost -$0.01 in the last trading session, representing a -0.77% loss.
What is InnoCan Pharma Corporation (INNPF) current market capitalization?
InnoCan Pharma Corporation market cap is approximately 5.80 million.
What is InnoCan Pharma Corporation (INNPF) Earnings Per Share (EPS)?
The trailing EPS is -$0.26.
What is InnoCan Pharma Corporation (INNPF) EBITDA?
InnoCan Pharma Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -193.00 thousand.
Does InnoCan Pharma Corporation (INNPF) pay dividends?
No. InnoCan Pharma Corporation does not pay a dividend.
What is InnoCan Pharma Corporation (INNPF) beta (volatility) score?
InnoCan Pharma Corporation has a beta of 0.297, indicating lower volatility than the overall market.
